Interaction between ECT and venlafaxine.
D000368:Aged; D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001262:Atenolol / Q000627:therapeutic use; D003131:Combined Modality Therapy / Q000009:adverse effects; D003511:Cyclohexanols / Q000627:therapeutic use*; D003863:Depression / Q000188:drug therapy*; D004565:Electroconvulsive Therapy / Q000379:methods*; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D000069470:Venlafaxine Hydrochloride
D018687:Antidepressive Agents, Second-Generation; D000959:Antihypertensive Agents; D003511:Cyclohexanols; D001262:Atenolol; D000069470:Venlafaxine Hydrochloride